GLP-1 and oral weight-loss medication comparison

Semaglutide vs Contrave: GLP-1 injection and naltrexone/bupropion comparison

Compare semaglutide and Contrave by labeled uses, route, mental-health and opioid warnings, GLP-1 safety questions, side effects, cost, follow-up, and online clinic red flags.

Educational guideUpdated June 14, 2026

Safe semaglutide vs Contrave comparison path

1

Name the exact option first: Wegovy, Ozempic, Rybelsus, compounded semaglutide, Contrave, generic naltrexone/bupropion discussions, or another clinician-reviewed medicine.

2

Match the reason for care: chronic weight management, type 2 diabetes context, cardiovascular-risk reduction, cravings or appetite support, weight maintenance, or another prescriber-reviewed goal.

3

Review safety before price: thyroid tumor warning history, pancreatitis or gallbladder history, severe GI symptoms, kidney risk from dehydration, seizure history, eating-disorder history, mood changes, suicidal thoughts, opioid use, blood pressure, pregnancy plans, and medication interactions can change the plan.

4

Compare the care model: intake depth, clinician review, pharmacy source, product status, side-effect support, lab or record review when relevant, follow-up, refill rules, stopping guidance, and cancellation terms.

5

Avoid no-prescription GLP-1 sellers, research-use semaglutide, “generic Ozempic” claims, online Contrave-like stacks, opioid-blocker surprises, seizure-risk shortcuts, and clinics that treat weight-loss medicines as automatic checkout products.

Direct answer

Semaglutide and Contrave are not interchangeable weight-loss medicines. Semaglutide is a GLP-1 receptor agonist used in product-specific pathways such as Wegovy, Ozempic, and Rybelsus. Contrave is an extended-release oral tablet that combines naltrexone and bupropion for chronic weight management with diet and exercise in eligible adults. A safer comparison depends on diagnosis, weight and glucose goals, mental-health history, seizure risk, opioid use, blood pressure, pregnancy plans, gastrointestinal tolerance, cost, and licensed clinician review.

Mechanism and label fit

What is the main difference between semaglutide and Contrave?

Semaglutide is a GLP-1 receptor agonist that affects appetite, glucose-related signaling, and gastric emptying. Contrave is a fixed-dose extended-release tablet containing naltrexone, an opioid antagonist, and bupropion, an antidepressant also used in other products. The comparison should start with the exact product and diagnosis because Wegovy, Ozempic, Rybelsus, compounded semaglutide, and Contrave each have different label contexts, routes, precautions, and follow-up needs.

  • Semaglutide review commonly focuses on GLP-1 product identity, thyroid tumor warning history, pancreatitis or gallbladder history, severe gastrointestinal symptoms, dehydration-related kidney risk, diabetes medicines, oral-medication timing, pregnancy plans, and pharmacy access.
  • Contrave review commonly focuses on mood or suicidal-thought warnings, seizure risk, eating-disorder history, abrupt alcohol or sedative changes, opioid use or dependence treatment, blood pressure, liver or kidney disease, pregnancy plans, and interacting antidepressants or MAOIs.
  • Neither option should be started, restarted, combined, or swapped based on social-media dose charts, compounded-drug claims, or a checkout quiz that does not reconcile the medication list.

Choosing a path

Which patients may be steered toward one discussion over the other?

A clinician may discuss semaglutide when GLP-1-specific chronic weight-management care, type 2 diabetes context, cardiometabolic risk, prior GLP-1 response, or branded or compounded semaglutide access fits the patient. Contrave may come up when an oral weight-management medication is being considered and opioid, seizure, psychiatric, blood-pressure, and interaction risks can be reviewed safely. The decision is not only about expected weight change; it depends on medical history, medications, pregnancy potential, side-effect tolerance, affordability, and follow-up capacity.

  • Semaglutide may be a better discussion when a patient needs GLP-1-specific obesity or diabetes care, weekly or oral semaglutide product review, non-stimulant planning, or clinician-managed maintenance support.
  • Contrave may be inappropriate or require extra caution for patients with seizure disorders, current or past bulimia or anorexia, uncontrolled hypertension, chronic opioid therapy, opioid-use-disorder treatment, recent opioid exposure, abrupt alcohol or sedative discontinuation, certain psychiatric histories, or recent MAOI use.
  • Patients should ask who coordinates primary care, mental-health care, pain management, diabetes medicines, blood-pressure monitoring, pregnancy-safety counseling, nutrition, side effects, refills, and stopping-plan questions.

Combination and switching questions

Do not self-combine semaglutide and Contrave from online stack advice

Some online discussions frame Contrave, separate naltrexone and bupropion prescriptions, phentermine, topiramate, or GLP-1 therapy as mix-and-match weight-loss stacks. That is unsafe without a coordinated prescriber. Overlap can change nausea, appetite, hydration, glucose trends, dizziness, blood pressure, sleep, mood symptoms, seizure risk, opioid pain-control options, and recognition of urgent symptoms. A switch or combination should have a clear diagnosis, medication list, monitoring plan, side-effect plan, refill rules, and instructions for what not to stop abruptly.

  • Ask whether A1C or glucose history, kidney function, blood pressure, seizure history, eating-disorder history, alcohol use, opioid exposure, mood history, pregnancy plans, and current medicines should be reviewed before a change.
  • Tell the clinician about opioid pain medicines, tramadol, buprenorphine, methadone, antidepressants, stimulants, seizure medicines, migraine medicines, blood-pressure medicines, diabetes medicines, sleep medicines, alcohol use, and supplements.
  • Avoid sellers that provide semaglutide vial math, Contrave-like ingredient stacks, opioid-blocker advice, bupropion dose shortcuts, no-prescription checkout, research-use GLP-1 products, guaranteed weight-loss claims, or instructions to stop psychiatric, pain, or seizure medicines without the managing clinician.

Online access

How should patients compare online clinics for these options?

A safer online clinic starts with diagnosis, medication history, and risk review. It should identify the exact product, explain FDA-approved brand status versus individualized compounded-prescription status, avoid implying compounded semaglutide is an FDA-approved finished drug product, use legitimate pharmacy channels, and provide follow-up. A low advertised monthly price may be misleading if it excludes clinician review, records or lab review when relevant, supplies, shipping, side-effect support, refills, blood-pressure or mental-health monitoring, or cancellation terms.

  • Ask whether the quote includes intake, clinician review, medication, pharmacy dispensing, supplies when needed, shipping, refills, side-effect support, medication-list reconciliation, and coordination with primary care, mental health, pain management, endocrinology, or OB-GYN when needed.
  • Ask whether compounded semaglutide is clearly described as not an FDA-approved finished drug product and whether pharmacy labels include active ingredient, route, strength or concentration, storage, and beyond-use date or expiration.
  • Be cautious with no-prescription peptide sellers, research-use semaglutide, “generic Ozempic,” unbundled naltrexone/bupropion stacks sold as a shortcut, guaranteed results, or pressure to buy bundles before clinician review.

Patient safety checklist

Questions to ask before choosing semaglutide or Contrave online

These points are educational and do not replace medical advice. A licensed clinician should review individual history, medications, risks, and state-specific availability before treatment.

✓

What exact medicine is being recommended: Wegovy, Ozempic, Rybelsus, compounded semaglutide, Contrave, separate naltrexone and bupropion, or another option?

✓

Is my goal chronic weight management, type 2 diabetes care, cardiometabolic risk reduction, appetite or cravings support, weight-regain prevention, or another clinician-reviewed reason?

✓

Have thyroid cancer or MEN2 history, pancreatitis or gallbladder disease, kidney disease, severe GI symptoms, seizure history, eating-disorder history, mood changes, suicidal thoughts, uncontrolled blood pressure, opioid use, alcohol or sedative changes, pregnancy plans, and breastfeeding questions been reviewed?

✓

Am I using insulin, sulfonylureas, opioids, tramadol, buprenorphine, methadone, antidepressants, stimulants, MAOIs, seizure medicines, migraine medicines, blood-pressure medicines, sleep medicines, alcohol, or supplements that should be coordinated?

✓

If compounded semaglutide is discussed, does the clinic clearly state that compounded semaglutide is not an FDA-approved finished drug product?

✓

If Contrave is discussed, who explains mood-warning monitoring, seizure-risk screening, opioid-blocking implications, blood-pressure checks, dose-titration expectations, and when treatment should be reassessed?

✓

How are labs or records, glucose monitoring, blood pressure, side effects, refills, missed doses, stopping therapy, travel, procedures, illness, maintenance, and medication changes handled?

✓

Does the seller avoid guaranteed weight-loss claims, no-prescription products, research-use vials, generic dosing charts, and pressure to buy bundles before clinician review?

FAQs

Short answers for patients

Is semaglutide the same as Contrave?

No. Semaglutide is a GLP-1 receptor agonist used in products such as Wegovy, Ozempic, and Rybelsus, with compounded access sometimes considered under individualized prescription. Contrave is an oral extended-release tablet that combines naltrexone and bupropion for chronic weight management in eligible adults. They have different mechanisms, warnings, side effects, routes, and follow-up needs.

Which works better for weight loss, semaglutide or Contrave?

There is no universal better option. Semaglutide products and Contrave have different evidence bases, labels, routes, contraindications, and monitoring needs. The right discussion depends on diagnosis, weight and glucose goals, mental-health history, seizure risk, opioid use, blood pressure, medications, cost, and prescriber judgment.

Can semaglutide and Contrave be taken together?

Do not combine weight-loss medicines unless the same licensed clinician reviews the full plan or coordinates with the clinicians managing related medicines. Combining options can change nausea, appetite, hydration, glucose readings, dizziness, mood symptoms, sleep, blood pressure, seizure risk, opioid pain-control planning, and side-effect monitoring.

Is compounded semaglutide FDA-approved?

No. Wegovy, Ozempic, and Rybelsus are FDA-approved brand-name semaglutide products for specific labeled uses. Compounded semaglutide, when clinically and legally appropriate for an individual prescription, is not an FDA-approved finished drug product and should not be marketed as generic Ozempic or Wegovy.

Who should be cautious with Contrave?

Patients should disclose seizure history, eating-disorder history, mood changes or suicidal thoughts, uncontrolled high blood pressure, opioid use or recent opioid exposure, opioid-use-disorder treatment, alcohol or sedative use changes, liver or kidney disease, pregnancy plans, breastfeeding questions, and all psychiatric, pain, sleep, stimulant, migraine, and seizure medicines.

How should cost be compared?

Compare the full care model, not only a monthly drug price. Ask whether the price includes intake, clinician review, medication, pharmacy dispensing, supplies when needed, shipping, records or labs when relevant, side-effect support, blood-pressure or mental-health monitoring, refill reassessment, cancellation rules, and branded versus compounded access.

Sources and related reading

Peptide12 pages use conservative educational language and authoritative sources where possible.

DailyMed: Wegovy (semaglutide) prescribing informationMedlinePlus: Semaglutide injectionDailyMed: Contrave (naltrexone hydrochloride and bupropion hydrochloride) prescribing informationMedlinePlus: Naltrexone and bupropionFDA: FDA's concerns with unapproved GLP-1 drugs used for weight lossFDA: Compounding and the FDA questions and answersPeptide12: Compounded semaglutide injectionPeptide12: WegovyPeptide12: OzempicPeptide12: Semaglutide vs phenterminePeptide12: Semaglutide vs topiramatePeptide12: Semaglutide vs metforminPeptide12: GLP-1 glucose monitoring questionsPeptide12: Medication interaction reviewPeptide12: Mental health history reviewPeptide12: Blood pressure medication questionsPeptide12: How online peptide therapy works